Robyn M Tamblyn
Robyn M Tamblyn publishes mostly in General Health Professions, Geriatrics and Gerontology and Public Health, Environmental and Occupational Health, on topics such as Pharmaceutical Practices and Patient Outcomes, Electronic Health Records Systems and Medication Adherence and Compliance.
- World rank
- #80,139 of 7,710,434 ranked researchers
- Rank in Canada
- #2,440 of 183,316
- Works
- 353
- Citations
- 20k
- Citations per work
- 56.8
What does Robyn M Tamblyn research?
Robyn M Tamblyn's work is mostly in Medicine (26%), Health Professions (18%), Economics, Econometrics and Finance (7%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else17348.9%
- Health Sciences15744.4%
- Medicine9426.5%
- Health Professions6317.9%
- Social Sciences246.7%
- 1General Health Professions11% of their works
- 2Geriatrics and Gerontology10% of their works
- 3Public Health, Environmental and Occupational Health9% of their works
- 4Family Practice7% of their works
- 5Health Information Management7% of their works
- 6Economics and Econometrics7% of their works
Research topics
- Pharmaceutical Practices and Patient Outcomes
- Electronic Health Records Systems
- Medication Adherence and Compliance
- Health Systems, Economic Evaluations, Quality of Life
- Innovations in Medical Education
- Primary Care and Health Outcomes
- Pharmacovigilance and Adverse Drug Reactions
- Patient Safety and Medication Errors
Which keywords describe Robyn M Tamblyn's research?
The keywords of their largest research topics: Inappropriate Medication Use, Polypharmacy, Chronic Disease Management, Medication Errors, Clinical Decision Support Systems, Electronic Health Records, Medication Adherence and Treatment Adherence.
- Patient Safety Culture
- Pharmacovigilance
- Quality Improvement
- Professional Identity Formation
- Quality of Life
- Treatment Adherence
- Electronic Health Records
- Medication Errors
- Polypharmacy
- Inappropriate Medication Use
- Chronic Disease Management
- Clinical Decision Support Systems
- Medication Adherence
- Cost-effectiveness Analysis
- Competency-Based Education
- Primary Care
- Adverse Drug Reactions
- Medical Errors
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 18 words, with their numbers
- Inappropriate Medication Use921 topic
- Polypharmacy921 topic
- Chronic Disease Management782 topics
- Medication Errors742 topics
- Clinical Decision Support Systems551 topic
- Electronic Health Records551 topic
- Medication Adherence541 topic
- Treatment Adherence541 topic
- Cost-effectiveness Analysis371 topic
- Quality of Life371 topic
- Competency-Based Education261 topic
- Professional Identity Formation261 topic
- Primary Care241 topic
- Quality Improvement241 topic
- Adverse Drug Reactions211 topic
- Pharmacovigilance211 topic
- Medical Errors191 topic
- Patient Safety Culture191 topic
Where does Robyn M Tamblyn work?
Robyn M Tamblyn's main affiliation in the publication record is McGill University, Canada.
How many publications and citations does Robyn M Tamblyn have?
OpenAlex counts 353 works and 20,038 citations for Robyn M Tamblyn, an h-index of 67, ranking #80,139 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Robyn M Tamblyn. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.